• Home
  • Search Results

Search Results

409 studies match your search
Open

The ARTMA Asthma Relief Study: Exploring New Treatments

Do you have asthma and sometimes experience attacks? You might qualify for our study testing a new rescue treatment. We're exploring if a treatment can help manage your symptoms. Join us to help shape future asthma care.

Age & Gender
  • 18 years ~ 65 years
  • Male, Female, Gender Inclusive
Study Interest
  • Lungs and Breathing
Open

BandPass: Using Technology To Improve Strength

Do you want to help in the design of a new device that can electronically measure and track your strength? We are testing a new system that uses an electronic resistance exercise band and an 'app' designed for older adults to improve strength and prevent weakness.

Age & Gender
  • 65 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Injury/Injury Prevention
  • Movement
  • and 2 more
Open

Efficacy of Tezepelumab in Peanut Oral Immunotherapy (Zenith)

Volunteers Needed! The ZENITH study may be an option for people 12-55 years old who are allergic to peanut.

Age & Gender
  • 12 years ~ 55 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
Open

Acetaminophen Versus Ibuprofen for Discomfort in Crohn's Disease

Do you have Crohn's disease and painful period cramps? You may be able to join a research study. We want to learn which pain medicine works best and is safest for people with Crohn's disease.

Age & Gender
  • 18 years ~ 44 years
  • Female
Study Interest
  • Stomach, Digestion and Gut Health
Open

ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients with Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy with HER2 Blockade

Are you 18 years or older and diagnosed with HER2+, clinical stage T1c-T3 (or Tx) and nodal stage N0-N1 breast cancer and prior to surgery did you received chemotherapy in combination with Trastuzumab for a minimum of 12 weeks? If so, you may be eligible for a research study evaluating the effectiveness of 6 months of HER2-targeted medications (trastuzumab with or without pertuzumab) versus 12 months of HER2-targeted medications at reducing the risk of breast cancer coming back or death in patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Mindful Miles: A Study for Athletes with Knee Pain

Do you feel pain at the front of your knee when you run, squat, jump, or use the stairs? If you're an athlete or runner experiencing this, you might be eligible to join our study to see how mindfulness while running can help ease knee pain, lower fear of injury, and improve how you run.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Injury/Injury Prevention
  • Wellness and Lifestyle
  • and 5 more
Open

AYA WELL

Are you an adolescent or young adult cancer survivor who would like to lose weight? Interested in using technology to support a healthy diet and get more physically active? Researchers are looking for volunteers to sign up for a 12-month research program that will involve using a Fitbit activity tracker and digital smart scale. For more information and to see if you qualify, visit our study website.

Age & Gender
  • 18 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Obesity
  • Movement
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Open

Study of Caregivers of Children with Asthma

Have you had trouble getting your child's asthma medication filled at the pharmacy? Have you been inconvenienced because of problems with the prescription, lack of insurance coverage for the drug, or need for a prior authorization? We want to hear from you about the problems you've faced and how we can make getting your child's asthma medication easier and more convenient. We are conducting a research study of caregivers that involves one virtual discussion session with a researcher and other caregivers of children with asthma. You will be compensated for your time.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Chronic Conditions
  • Minority Health
  • and 4 more
Visit Location
100% Remote (online, phone, text)
Open

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Do you have Stage III or IV Squamous Cell Skin Cancer that is considered high risk? If so,you may be able to take part in a research study evaluating combination therapies versus the standard approach for your type of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Memory for changes in Aging

Are you between the ages of 18 and 35 or 65 and 85? Are you interested in contributing to research that wants to understand how human memory works? If so, you may be able to take part in a study on how younger and older adults learn and remember words. You can help us learn more about how memory works in adults! Compensation provided.

Age & Gender
  • 18 years ~ 85 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Healthy Volunteer or General Population
  • Opinions and Perceptions
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research